Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • fritzwebSTANNA
    Junior Member
    • Oct 2015
    • 2

    #1

    osteosarcoma survival data set

    Hi all,

    I am a researcher at St. Anna Children's Cancer Research Institute in Vienna, Austria.

    I was wondering if anyone of you would know a publicly available dataset of osteosarcoma survival times (from day of diagnosis or day of first surgery). That would be highly appreciated.
    Also, I am interested in Ewing sarcoma and soft-tissue sarcoma dataset.

    Thank you so much in advance for your help!

    Best regards
    Friedrich Erhart
  • papori
    Senior Member
    • Dec 2010
    • 181

    #2
    Originally posted by fritzwebSTANNA View Post
    Hi all,

    I am a researcher at St. Anna Children's Cancer Research Institute in Vienna, Austria.

    I was wondering if anyone of you would know a publicly available dataset of osteosarcoma survival times (from day of diagnosis or day of first surgery). That would be highly appreciated.
    Also, I am interested in Ewing sarcoma and soft-tissue sarcoma dataset.

    Thank you so much in advance for your help!

    Best regards
    Friedrich Erhart
    Hi Friedrich ,
    Did u try the data from the TCGA?
    i know there is alot of clinical data.
    Cheers
    Last edited by papori; 10-15-2015, 12:58 AM.

    Comment

    • fritzwebSTANNA
      Junior Member
      • Oct 2015
      • 2

      #3
      Yes, I tried that. They have a lot of gene expression datasets for adult sarcomas. What I am looking for, however, are survival data sets for pediatric osteosarcoma, Ewing sarcoma and soft-tissue sarcoma.

      Thank you all for your help! :-)

      Comment

      • GenoMax
        Senior Member
        • Feb 2008
        • 7142

        #4
        You may have to find relevant paper(s) and then contact the authors to get survival data. I am not if you are going to find this information from a public resource.

        Comment

        • freidariviere
          Junior Member
          • Oct 2015
          • 1

          #5
          I think though the answer to your question can come from common sense . . osteosarcoma is an aggressive type of bone cancer and it stands to reason that if a patient is found at an early stage of the disease it is far easier to treat successfully than when it is in an advanced state. But there are no guarantees . . even in the early stages osteosarcoma is aggressive and nasty enough that heavy duty treatments are often required to PREVENT it from advancing. Survival depends on many factors . . age of patient, patients overall health, location of tumors, grade of tumor, and patients response to first line treatment . . not to mention a good amount of 'luck'. People with single tumors who might not survive would include those who are in poor health to begin with, those unable to undergo treatments, those who succumb to the treatment or surgery, those whose age works against them, those who do not survive infections or those who due to other health issues cannot complete or must use reduced treatment options .. and there may be other reasons as well.
          Fitness Subscription Box, Workout Subscription Box, Healthy Subscription Boxes

          Comment

          Latest Articles

          Collapse

          • SEQadmin2
            Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
            by SEQadmin2



            Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

            Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
            ...
            10-14-2026, 09:55 AM
          • SEQadmin2
            New Genomics Technologies Take Aim at Long-Standing Limits
            by SEQadmin2


            Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

            We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
            ...
            09-28-2026, 10:25 AM

          ad_right_rmr

          Collapse

          News

          Collapse

          Topics Statistics Last Post
          Started by SEQadmin2, Yesterday, 11:13 AM
          0 responses
          19 views
          0 reactions
          Last Post SEQadmin2  
          Started by SEQadmin2, Yesterday, 10:48 AM
          0 responses
          18 views
          0 reactions
          Last Post SEQadmin2  
          Started by SEQadmin2, 10-15-2026, 10:52 AM
          0 responses
          36 views
          0 reactions
          Last Post SEQadmin2  
          Started by SEQadmin2, 10-14-2026, 05:39 AM
          0 responses
          42 views
          0 reactions
          Last Post SEQadmin2  
          Working...